###### Key questions

What is already known about this subject?
=========================================

-   The indirect method for quantification of mitral regurgitations is reproducible and superior to echocardiographic methods. Literature suggests that stroke volumes measured with phase contrast flow in aorta decrease with increasing distance from the aortic valve, but there is no consensus on where to measure flow in aorta and how choice of level impacts calculated mitral regurgitations by the indirect method.

What does this study add?
=========================

-   In participants with no structural abnormalities of the large vessels, stroke volumes measured with flow in aorta decreases with increasing distance from the aortic valves and stroke volumes are systematically lower when compared with volumetric measurements irrespective of breath-hold regimen. This results in an overestimation of calculated mitral regurgitations when using the indirect method ranging from 8% at the aortic valve level, 12% at the sinotubular junction and 15% in the mid-ascending aorta.

How might this impact on clinical practice?
===========================================

-   A clear indication of the level of measurement should always be reported for clinicians to assess how measurement method could possibly affect results. Choice of distal level of measurement may result in overestimation of mitral regurgitations.

Introduction {#s1}
============

Cardiovascular magnetic resonance imaging (CMR) is the gold standard for measuring volumes in the heart and is widely used for this purpose in research and clinical practice. Mitral regurgitations can be assessed by CMR with the indirect method by subtracting the forward phase contrast (PC) flow in aorta from the detailed volumetric segmentation of the left ventricle.[@R1] A recent review[@R2] highlights CMR as superior to 2D and 3D echocardiography in quantification of mitral regurgitations and advocates the use of CMR in future studies and clinical assessments. Despite its many advantages, CMR is also subject to method-specific errors and it is essential that these limitations are known and taken into account when reporting CMR-derived measurements.[@R3]

CMR studies have shown that stroke volume (SV) determined in the ascending aorta with 2D PC flow in healthy controls decrease the more distally in the ascending aorta the measurement is performed,[@R4] and the phenomenon is even more pronounced under pathological conditions.[@R5] While a recent consensus statement recommends measuring forward aortic volume at the level of the sinotubular (ST) junction,[@R9] different measurement locations in the aorta are regularly used ([table 1](#T1){ref-type="table"}). In some studies, measurements from different locations are used indiscriminately,[@R10] and some studies do not report the location of flow measurement.[@R11]

###### 

Overview of studies on assessment of mitral regurgitation with CMR

  First author and reference   Year   n     Reported level of measurement
  ---------------------------- ------ ----- -------------------------------------------------------------------------------------------------------------------------------------------
  Hundley *et al*[@R1]         1995   17    2 to 4 cm above the aortic valve
  Kizilbash *et al*            1998   22    Ascending aorta, well above the aortic valve and coronary ostia
  Gelfand *et al*              2006   83    The axial plane at the level of the bifurcation of the pulmonary artery
  Buck *et al*                 2008   73    Orthogonal to the mid-ascending aorta
  Uretsky *et al*[@R12]        2010   23    Not reported
  Myerson *et al*[@R10]        2010   55    Just above the aortic valve
  Shanks *et al*               2010   30    2 to 5 cm above the aortic valve, where the aorta was nearly parallel to the caudal cranial axis of the patient, in the axial orientation
  Hamada *et al*               2012   43    10 mm above the tip of the aortic valve
  Cawley *et al*               2013   26    Aortic valve
  Van De Heyning *et al*       2013   38    Ascending aorta
  Thavendiranathan *et al*     2013   30    1 to 2 cm above the aortic valve
  Choi *et al*                 2014   52    2 to 3 cm above the aortic valve
  Uretsky *et al*[@R11]        2015   103   Not reported
  Sachdev *et al*[@R13]        2017   58    Not reported
  Lopez-Mattei *et al*         2016   70    Sinotubular junction
  Aplin *et al*[@R22]          2016   72    Sinotubular junction
  Myerson *et al*[@R23]        2016   109   Just above the aortic valve at end diastole or at the sinotubular junction
  Harris *et al*               2017   22    Across the aortic valve
  Polte *et al*                2017   40    Sinotubular junction
  Heo *et al*                  2017   37    2 to 3 cm above the aortic valve
  Penicka *et al*[@R24]        2018   258   2 to 3 cm above the aortic valve
  Chew *et al*[@R30]           2019   109   At the aortic sinotubular junction or just above the valve prosthesis post-replacement

CMR, cardiac magnetic resonance imaging.

Furthermore, studies have found a systematic difference, with volumetrically segmented SV being several millilitres greater than SV based on flow measurements.[@R8] Consequently, this may result in systematic overestimation of calculated atrioventricular regurgitations. Theoretically, this could be caused by different breath-hold regimens between volumetric and flow measurements.[@R16] It has been suggested that, if performed correctly, free-breathing and breath-hold PC flow can be used interchangeably[@R7] while others disagree.[@R4]

The aim of this study was to quantify the impact of changing image planes between the most frequently used locations in aortic flow measurements. Second is to evaluate the impact of breath-hold regimen as well as evaluate the corresponding 'false' regurgitant volume with the indirect method. To provide a best-case scenario, the study was performed in subjects with no abnormalities of the large vessels.

Methods {#s2}
=======

Participants were recruited from a clinical study including patients with known paroxysmal atrial fibrillation and a healthy control group from October to December 2017. All included participants had a full CMR and no previously known structural heart disease. Participants were excluded if they could not comply with instructions, experienced arrythmia during the scan, if CMR revealed pathological conditions of valves or vessels of interest, or if any flow measurements were of unacceptable quality.

All participants were at least 18 years of age and signed informed written consent prior to scanning. Patient or public involvement was not considered appropriate.

Image acquisition {#s2-1}
-----------------

All scans were performed on a 1.5 T Siemens Aera (Erlangen, Germany) and corresponded to normal clinical scans.

Long-axis cine images (two-chamber, three-chamber and four-chamber) were acquired initially. Volumetric measurements were performed with SSFP cine sequences (typical imaging parameters: 8 mm slice thickness; 2 mm gap; pixel size 1.9×1.9 mm; 25 phases; TR/TE 2.6/1.1 ms) during end-expiratory breath-holds. An axial stack ranging from basis to the aortic arch and a short-axis stack covering the entire left ventricle were obtained.

Flow (through plane phase contrast) sequences corresponding to normal clinical flow sequences were performed. A free-breathing (FB) and a breath-hold (BH) sequence were performed at each plane as depicted in [figure 1](#F1){ref-type="fig"}: in the pulmonary trunk (PA) and at three levels in the aorta. For measurements at aortic valve level (Va), the imaging plane was placed at the tip of the open aortic valve leaflets in systole always proximal to the coronary arteries. At the ST junction, the imaging slice was placed just distal to the aortic sinus. At the mid-ascending aorta, the slice in the axial stack displaying the pulmonary bifurcation was copied without corrections to the flow sequence as described in the literature.[@R18] For positioning of all flow planes (except the mid-ascending aorta) perpendicularly to the vessels, two orthogonal images were obtained. Imaging parameters for the two flow sequences are reported in [table 2](#T2){ref-type="table"}. To minimise phase offset errors, vessels were placed along the z-axis as close to the isocentre as possible. Velocity encoding was set to 200 cm/s.

![Illustration of included flow measurements. (A, B) Three-chamber and orthogonal cine images showing levels of flow measurements in aorta at valve level (green line), sinotubular junction (red line) and mid-ascending aorta (yellow line). (C, D) Right ventricular outflow tract and pulmonary trunk and orthogonal cine images showing level of flow measurement in the pulmonary artery (blue line). Ao, aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery/trunk; RV, right ventricle.](openhrt-2020-001323f01){#F1}

###### 

Acquisition parameters for phase contrast flow sequences

                                 Breath-hold             Free-breathing
  ------------------------------ ----------------------- -----------------------
  TR/TE (ms)                     4.64/2.47               5.09/2.8
  Flip angle (°)                 20                      20
  Bandwidth (Hz/pixel)           450                     455
  Slice thickness (mm)           6                       5
  Matrix size (voxels)           (126--192)×(126--256)   (168--256)×(176--256)
  Pixel size (mm)                1.77×1.77               1.33×1.33
  Frames/cycle                   30                      50
  Typical acquisition time (s)   13--17                  150--180
  Averages                       1                       3

TE, echo time; TR, repetition time.

Image analyses {#s2-2}
--------------

All images were analysed in CVI^42^ V.5.6.6 (Circle Cardiovascular Imaging). On short-axis cine images, left ventricular (LV) end-diastolic and end-systolic phases were traced manually at the endocardial and epicardial border. LV outflow tract was included in the blood pool; papillary muscles were excluded, using windowing for the endocardial border. Epicardium was delineated in both phases to compare left myocardial mass in end-diastole and end-systole. The right ventricle was traced manually on axial cine images in end-diastolic and end-systolic phases and trabeculation was included in the blood pool. Right ventricular outflow tract was included in the blood pool. Cross-sectional images of valves were carefully referenced to determine distinction between ventricular blood pool and atrial and vascular blood pool.

Flow sequences were measured semi-automated with manual correction, carefully tracing the outer vessel wall. Images and flow curves were assessed for signs of arrhythmia during scanning and aliasing. As we wanted the setting to be as similar to a clinical workflow as possible, we did not perform phantom corrections. Background correction was performed on all uniform muscle tissue in the magnitude image.[@R15] Forward flow, representing SV, was registered for all images (pulmonary artery, aorta at valve level, ST junction and mid-ascending aorta with breath-hold and free-breathing sequences, respectively). Heart rate for each sequence was registered. Peak velocity for each flow measurement was registered in 2×2 pixels to avoid errors on pixel level.[@R20] Q~p~/Q~s~ ratios were calculated as pulmonary SV measured with PC flow divided by systemic SV measured with PC flow at different levels in the aorta.

The axial cine stack and two-chamber, three-chamber and four-chamber cine images were visually inspected for mitral and tricuspid regurgitations. The flow measurements were not taken into consideration when assessing valvular regurgitation.

Statistics {#s2-3}
----------

All data are reported as means and SD unless stated otherwise. Paired t-tests were performed to compare flow measurements. P values less than 0.05 were considered statistically significant.

First, to assess the effect of breathing regimen, flow assessments with FB and BH sequences were compared for each imaging level with paired t-tests and Bland-Altman plots were constructed.[@R21] Due to the flow in the coronary arteries, flow comparisons were limited to flow in aorta at valve level versus the pulmonary artery and in aorta at ST junction versus mid-ascending aorta. Bland-Altman plots were visually inspected for trumpet shapes as a sign of increasing effect with increasing SV.

Subsequently, for assessment of a possible bias when calculating mitral regurgitations with the indirect method, differences between flow and volumetric measurements were compared with paired t-tests and Bland-Altman plots. In this second analysis, participants with visible mitral or tricuspid regurgitations were excluded from left-sided and right-sided measurements, respectively. The resulting 'false' regurgitant volume was calculated for each measurement.

Results {#s3}
=======

Initially, 50 participants were included. Three participants were excluded due to frequent premature ventricular contractions. Three participants were excluded due to inability to comply with BH instructions. Two participants were excluded due to bicuspid aortic valves (not previously known). Three participants were excluded due to a single flow measurement of unacceptable quality (two FB valve flows due to inability to make a precise delineation of the valve because of too much blurring and one BH pulmonary flow due to wrap over the artery, not noticed during the scan). Consequently, 39 participants with no abnormalities of the large vessels and complete flow measurements were included in the analyses. Nine participants had visible mitral regurgitation. Thirteen had visible tricuspid regurgitation. Baseline characteristics of participants are reported in [table 3](#T3){ref-type="table"}.

###### 

Baseline characteristics of included patients

  N                                            39
  -------------------------------------------- -----------------------------
  Age, years (IQR)                             42.5 (38.6--45.1)
  Height, cm (SD)                              182.2 (8.6)
  Weight, kg (SD)                              86.1 (11.4)
  Male sex, n (%)                              32 (82)
  Hypertension, n (%)                          3 (2 without treatment) (8)
  Diabetes mellitus, n (%)                     0 (0)
  Ischaemic heart disease, n (%)               0 (0)
  Paroxysmal atrial fibrillation, n (%)        26 (67)
  LV EDV, mL/m^2^ (SD)                         92.5 (14.7)
  LV ESV, mL/m^2^ (SD)                         37.7 (7.8)
  LV SV, mL/m^2^ (SD)                          54.9 (9.2)
  LV EF (%)                                    59.4 (5.0)
  LV myocardial mass (diastole), g/m^2^ (SD)   62.4 (11.0)
  RV EDV, mL/m^2^ (SD)                         96.9 (17.2)
  RV ESV, mL/m^2^ (SD)                         43.1 (9.1)
  RV SV, mL/m^2^ (SD)                          53.7 (9.7)
  RV EF (%)                                    55.6 (4.4)

Values are shown as mean (SD) or median (IQR).

EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; LV, left ventricle; RV, right ventricle; SV, stroke volume.

BH regimens {#s3-1}
-----------

There were no statistical differences between FB and BH flows, except at valve level ([table 4](#T4){ref-type="table"}). As summarised in [online supplementary table S1](#SP1){ref-type="supplementary-material"}, background correction changed FB more than BH sequences, hence FB and BH flow measurements before background correction were statistically different. Bland-Altman plots of FB flow compared with BH flow showed no increased difference with increasing SV ([online supplementary figure S1](#SP1){ref-type="supplementary-material"}). The limits of agreement were ±14.3 mL for the pulmonary artery while similar for all aorta flows (valve ±9.9 mL, ST junction ±10.4 mL and mid-ascending ±9.9 mL), and all showed none to very small bias from zero.
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###### 

Mean stroke volumes measured in aorta and in the main pulmonary artery and corresponding Q~p~/Q~s~ ratios

  ---------------------------------------------------------------------------------
  n=39                           FB                  BH                  P value\
                                                                         FB vs BH
  ------------------------------ ------------------- ------------------- ----------
  Valve level                                                            

   Stroke volume, mL (SD)        107.5 (20.2)        104.1 (19.6)        \<0.001

   Q~p~/Q~s~, mean (range)       0.98 (0.78--1.10)   1.02 (0.85--1.21)   

  ST-junction level                                                      

   Stroke volume, mL (SD)        99.1 (20.2)         99.9 (20.2)         0.3

   Q~p~/Q~s~, mean (range)       1.06 (0.89--1.29)   1.07 (0.96--1.23)   

  Mid-ascending aorta                                                    

   Stroke volume, mL (SD)        96.2 (20.8)         96.2 (20.6)         1.0

   Q~p~/Q~s~, mean (range)       1.10 (0.94--1.21)   1.11 (0.91--1.29)   

  Pulmonary artery                                                       

   Stroke volume, mL (SD)        104.5 (21.1)        106.0 (20.5)        0.2

  P values for flow vs flow                                              

  Valve vs pulmonary             0.02                0.1                 

  ST junction vs mid-ascending   0.01                \<0.001             
  ---------------------------------------------------------------------------------

P values for paired t-tests between stroke volumes.

Q~p~/Q~s~ should be 1 before the coronary arteries (valve level) and 1.05 after the coronary arteries (ST junction and mid-ascending aorta).

BH, breath-hold; FB, free-breathing; Q, flow rate; Q~p~/Q~s~, pulmonary flow divided by systemic flow; ST junction, sinotubular junction.

Comparisons of peak velocities, heart rates and artefacts between FB and BH sequences are reported in [online supplementary material](#SP1){ref-type="supplementary-material"}.

Flow signal in the aortic root {#s3-2}
------------------------------

[Table 4](#T4){ref-type="table"} summarises the SV measured at the three different levels in the aortic root and in the main pulmonary artery. A decrease in aortic flow volume was seen with increasing distance to the valve. [Figure 2](#F2){ref-type="fig"} depicts how this was directly evident in the majority of the participants. A decrease of 5% would be expected between aortic valve and ST junction, due to coronary flow, but the additional decrease between ST junction and mid-ascending aorta was also statistically significant. The corresponding Q~p~/Q~s~ ratios also increased with increasing distance from the valves ([table 4](#T4){ref-type="table"}).

![Individual flow measurements in aorta. Stroke volumes measured with phase contrast flow at indicated levels in the aortic root (valve, ST junction and mid-ascending). (A) Free-breathing flow measurements. (B) Breath-hold flow measurements. Red line indicates mean values. Notice how measured stroke volumes decrease with increasing distance to the valve. ST, sinotubular.](openhrt-2020-001323f02){#F2}

Bias between flow and volumetric measurements {#s3-3}
---------------------------------------------

[Figure 3](#F3){ref-type="fig"} shows Bland-Altman plots for FB and BH flow measurements compared with corresponding volumetric measurements. In these comparisons, participants with visible mitral regurgitations (for left-sided comparisons) and tricuspid regurgitations (for right-sided comparison) have been excluded and therefore the volumetric measurements should theoretically be equal to SV measured with flow, though 5% lower when measured in the aorta distal to the coronary arteries. Nevertheless, we found a bias between volumetric measurements and BH flow SV increasing from 10.6 mL on valve level to 14.0 mL on ST junction and further to 17.7 mL in mid-ascending aorta. On the right side, a mean difference of 4.8 mL was found. Comparisons with FB showed similar results for ST junction (15.3 mL) and mid-ascending aorta (17.8 mL) but a smaller bias at valve level (6.4 mL) ([online supplementary table S2](#SP1){ref-type="supplementary-material"}).

![Bland-Altman plots volumetric vs flow measurements. The continuous line represents the mean and the dotted line represent the 95% limits of agreement for SV measured with FB and BH flow, respectively, at indicated place compared with corresponding volumetric measurement. Dotted red line indicates no bias. (A, E) Valve level. (B, F) ST junction. (C, G) Mid-ascending aorta. (D, H) Pulmonary artery. Corresponding paired t-tests are indicated. In left-sided measurements, patients with mitral regurgitation have been excluded (n=30). In right-sided measurements patients with tricuspid regurgitation have been excluded (n=26). BH, breath-hold; FB, free-breathing; ST, sinotubular; SV, stroke volume.](openhrt-2020-001323f03){#F3}

In clinical assessment of mitral or tricuspid regurgitations, the found bias would, employing the indirect method, result in a 'false' regurgitant volume as presented in [figure 4](#F4){ref-type="fig"}. This overestimated volume resulted in calculated regurgitation fractions in healthy young participants with no visible regurgitation of 8.0% (SD 5.8) for BH measurements at valve level, 11.6% (SD 5.2) at the ST junction, 15.3% (SD 5.0) at the mid-ascending aorta and 3.8% (SD 8.3) in the pulmonary artery.

![Measured stroke volumes and corresponding calculated 'false' regurgitant fraction. Mean stroke volumes measured volumetrically in left (LVvol) and right (RVvol) ventricle and with FB and BH flow at valve level (flow valve), sinotubular junction (flow ST), mid-ascending aorta (flow MA) and the pulmonary artery (flow PA). In left-sided measurements (LVvol, flow valve, flow ST and flow MA), patients with mitral regurgitation have been excluded (n=30). In right-sided measurements (RVvol and flow PA), patients with tricuspid regurgitation have been excluded (n=26). Results are summarised in [online supplementary table S2](#SP1){ref-type="supplementary-material"}. Note that LV volumetric and flow at valve level should theoretically be similar, but that flow at the ST junctions is expected to be 5% lower because of the coronary arteries. A further fall at the mid-ascending aorta is not expected. The RV-volumetric and pulmonary flow should theoretically be similar as well. Below the x-axis are the corresponding calculated atrioventricular regurgitation fractions. Regurgitant volume is calculated by subtracting forward phase contrast flow in aorta at specified measurements level from the volumetric segmentation. \*p=0.01, \*\*p\<0.001, \*\*\*p\<0.0001. BH, breath-hold flow; FB, free-breathing flow; LV, left ventricle; RV, right ventricle; ST, sinotubular.](openhrt-2020-001323f04){#F4}

Discussion {#s4}
==========

This study demonstrates fundamental problems in assessment of mitral regurgitation using the most commonly applied CMR approach. Our study shows that in subjects with no abnormalities of the large arteries, CMR 2D PC flow measurements decrease from the aortic valve throughout the aortic root and ascending aorta. Compared with volumetric measurements, flow measurements underestimate SV. This difference results in a calculated 'false' atrioventricular regurgitant volume when applying the most common method for assessing mitral regurgitations, the indirect method. Calculated mitral regurgitations increased from 8% at valve level to 15% in the mid-ascending aorta. The difference was not affected by different BH regimens.

As described in recent reviews,[@R2] CMR quantification of mitral regurgitation is reproducible and has shown its superiority compared with other methods in large studies.[@R11] Even though quantification of aortic flow is essential to the indirect CMR assessment of regurgitations, some of these studies use the different measurement planes equally or do not report the location of the aortic flow measurement ([table 1](#T1){ref-type="table"}). Hence, based on the results from the present study, these studies may have overestimated calculated mitral regurgitations by up to 15%. Because the conditions in the present study represent a best-case scenario, the actual overestimation is possibly even larger.

Mitral regurgitation assessments with the indirect method {#s4-1}
---------------------------------------------------------

A different issue with the indirect quantification method is the combination of two different means of measurement, the volumetric segmentation and the forward flow measurement. First, the measurements are not performed simultaneously and a change in cardiac output during the scan, which is not uncommon due to initial patient nervousness associated with being in the scanner and subsequent accommodation to the unfamiliar environment, often results in a fall in cardiac output. Second, reproducibility tests of PC flow have shown high consistency of mean values and when analyses are repeated on the same images or images are repeated on the same patient, the SV measured with PC flow vary, typically in the range of ±10--15 mL.[@R4] The volumetric measurements also provide high reproducibility in the range of approximately ±10 mL.[@R26] Therefore, calculations of mitral regurgitations combining a volumetric and a flow measurement increase the variation and a true value should be expected within approximately ±20--25 mL. Hence, studies on many patients may provide high reproducibility and precision, but in clinical praxis we often struggle with variation in measurements and how to interpret the results for the individual patient. This issue is highlighted by Gulsin *et al*[@R27] stating that it is not uncommon that measured flow is higher at the ST junction compared with valve level even though the opposite would be expected due to the position of the coronary arteries between the two locations. This is also evident in [figure 2](#F2){ref-type="fig"} where flow SV of a few participants are not decreasing throughout the aortic root as it is for the majority. This may in part be due to the variation seen in flow measurements and of course be due to the fact that PC flow is very susceptible to artefacts and arrhythmias.[@R28]

To further complicate matters, in contrast to the presently found underestimation of forward flow in aorta when compared with volumetric assessment, the presence of aortic stenoses and hence high flow velocities often result in overestimation of forward flow in aorta.[@R8] Thus, in this context, the indirect method may result in underestimation of possible mitral regurgitations, which is often coexisting with aortic stenosis.[@R30]

The indirect method furthermore relies on the volumetric assessment as reference. Despite being the gold standard,[@R18] this method has several limitations. Results of volumetric measurements are highly dependent on uniform BHs, correct delineation and especially the basal slice will have a major contribution to the results, and it is thus important whether it is included in the blood pool or not, though the slice may be precisely in the mitral valve.

Turbulence and complex flow {#s4-2}
---------------------------

A previous study has speculated that the systematic difference between flow and volumetric measurements could be caused by the different physiology during BH used for cine sequences versus FB used for flow sequences.[@R8] The present study contradicts this hypothesis because FB and BH flow sequences produce similar results, suggesting that the observed differences between volumetric and 2D PC flow measurement may be an inherent problem with the 2D PC flow method. The flow pattern in the ascending aorta is complex, though under normal conditions approximately laminar until late systole where it forms a right-handed helix pattern as well as vortical flow (flow resolving around an axis) in the sinus of Valsalva. In patients with pathological conditions, the flow becomes more complex and forms turbulence, acceleration and a more pronounced vortical and helical flow pattern.[@R31] As 2D PC flow is only measuring flow in one plane, it is prone to underestimation and complex flow patterns will result in lower volumes measured. Several studies have found clearly reduced measured 2D PC aortic flow in patients with increased turbulence,[@R5] while as demonstrated by Nordmeyer *et al*, this is not a problem with 4D flow in healthy volunteers.[@R31] The found reduction in measured SV may very well be a result of increasing turbulence with increasing distance to the valve, even in healthy subjects. 4D flow furthermore allows direct quantification of regurgitant volumes employing a dynamic measurement plane by tracking the mitral annulus throughout the cardiac cycle.[@R32] Studies suggest[@R31] that 4D flow measurements could possibly solve many of the issues addressed in the present paper, but besides requiring extensive training, 4D flow is currently not commercially available on all scanners.

In 2D PC imaging, it is very important that flow is perpendicular to the imaging slice. Valve images and ST-junction images were carefully planned orthogonally to aorta whereas the mid-ascending images were copied from the axial stack and hence could result in some angulation to the aorta. This would be expected to be within ±15 degrees that should be compensated for by the simultaneous increase in vessel area and increase in partial volume effects,[@R29] thereby not causing the lower SV measured at the mid-ascending aorta.

Clinical flow measurements {#s4-3}
--------------------------

For a clinical workflow, the optimal flow assessment should have no phase offset error and should require very little post-processing work. Intuitively, the mid-ascending aorta seems the obvious choice. However, as indicated by the present study, in choosing such a distal image position in the aorta, one also introduces a significant systematic error. This was evident for FB as well as BH sequences. Essential to this point, our study provides a best-case scenario since the subjects in the present study were all healthy. Nevertheless, flow measurements systematically decrease in aorta and result in increasing overestimation of mitral regurgitation of up to 15%. Structural abnormalities in the aortic valve or ascending aorta, which are often present in patients referred for CMR, may introduce even larger errors.[@R5] It is unpredictable how large the loss of SV due to turbulence in each case will be and it can therefore not simply be corrected for by adding the approximated 'lost volume'.

When studying atrioventricular valve regurgitations using CMR, we therefore recommend that

-   Multiple CMR techniques are used in order to get a detailed description of the condition and a reliable conclusion.[@R9]

-   Flow is reported as a mean of at least two consecutive acquisitions due to the possible errors in flow measurements.

-   Flow measurements in the mid-ascending aorta are avoided or used with caution.

-   Background correction is applied and the effect on the results evaluated.

Limitations {#s4-4}
-----------

All scans were performed on a Siemens Aera scanner, and results could vary on other magnetic resonance scanners.

PC sequence parameters for FB and BH were not identical ([table 2](#T2){ref-type="table"}) which may impact the comparison between these methods. The sequences used correspond to clinical scans, and the results are hence clinically applicable.

A limitation of the present study is the use of the volumetric assessment as reference. As described previously, this similarly applies to the indirect method.

We only performed flow in the pulmonary trunk at one level and cannot say whether flow signal changes throughout the pulmonary trunk.

Conclusion {#s5}
==========

Mitral regurgitations are systematically overestimated by the indirect method combining CMR PC flow and volumetric segmentations. The overestimation ranged from 8.0% at valve level to 12% at the ST junction, and 15% at the mid-ascending aorta in participants with no abnormalities of the large vessels and no visible atrioventricular regurgitations. There were no differences between BH and FB sequences.
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